Evidence map›Paper›PMID 31862958›Full record

ArticleLeukemia2020

Recommendations for cytogenomic analysis of hematologic malignancies: comments from the Francophone Group of Hematological Cytogenetics (GFCH).

Florence Nguyen-Khac, Audrey Bidet, Lauren Veronese, Agnes Daudignon, Dominique Penther, Marie-Bérengère Troadec, Christine Lefebvre, Marina Lafage-Pochitaloff

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Florence Nguyen-KhacCell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, INSERM UMRS 1138, Paris, France. florence.nguyen-khac@aphp.fr.ORCID http://orcid.org/0000-0003-3107-6668
Audrey BidetCHU Bordeaux, Laboratoire d'Hématologie Biologique, F-33000, Bordeaux, France.
Lauren VeroneseService de Cytogénétique Médicale, CHU Estaing, 1 place Lucie et Raymond Aubrac, 63003, Clermont-Ferrand, France.
Agnes DaudignonInstitut de Génétique Médicale-Hôpital Jeanne de Flandre-CHRU de Lille, Av. Eugène Avinée, 59037, Lille Cedex, France.
Dominique PentherLaboratoire de Génétique Oncologique, Centre Henri Becquerel, rue d'Amiens, 76038, Rouen, France.
Marie-Bérengère TroadecUniv Brest, Inserm, EFS, UMR 1078, GGB, F-29200, Brest, France.
Christine LefebvreUnité de Génétique des Hémopathies - Institut de Biologie et Pathologie, CHU Grenoble Alpes, 38043, Grenoble, France.
Marina Lafage-PochitaloffLaboratoire de Cytogénétique Hématologique CHU Timone Aix Marseille University, Marseille Cedex, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematologic NeoplasmsHematologyCytogenetic AnalysisCytogeneticsHumans

Identifiers

PMID31862958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.